Dados B3Stocks › PNVL3 PT

Consumo Cíclico

PNVL3 — DIMED SA DISTRIBUIDORA DE MEDICAMENTOS

CNPJ 92.665.611/0001-77 · listed classes: PNVL3, PNVL4 · CVM code 9342

17.0P/E
1.7P/B
6.6EV/EBITDA
14.8%FCF yield
9.9%ROE 2025
9.5%ROIC 2025
P/E, P/B and EV/EBITDA priced at the session of 2026-03-19 (R$ 14.23), the first one after the 2025 filing became public on 2026-03-19 — point-in-time, not the 31 December price.

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator2010201120122013201420152016201720182019202020212022202320242025
ROE 17.8%!20.1%21.8%22.0%16.8%13.8%14.6%14.8%16.8%15.5%7.3%0.0%8.0%8.1%8.8%9.9%
ROIC 22.2%!23.3%23.7%21.7%16.6%14.5%15.1%15.6%16.6%14.9%8.4%!7.0%8.2%!8.8%!8.7%9.5%
ROA 8.2%!9.1%10.0%10.2%7.5%6.1%6.7%6.8%7.7%6.2%3.1%3.5%3.4%3.2%3.3%3.5%
Gross margin 21.5%21.6%22.5%21.9%22.2%22.7%24.4%23.8%29.4%29.7%29.2%30.7%31.1%30.9%31.8%32.4%
EBIT margin 4.5%4.3%4.5%4.4%4.0%4.2%4.3%4.2%4.6%4.4%3.3%3.1%3.4%3.7%4.0%4.6%
Net margin 2.6%2.8%3.1%3.2%2.6%2.3%2.5%2.6%3.1%2.8%2.0%2.5%2.2%2.1%2.1%2.3%
Revenue growth (1y) 13.3%13.3%14.2%8.4%5.2%7.2%6.1%7.7%12.0%3.5%14.4%23.7%11.8%10.8%11.5%
Revenue growth (5y CAGR) 10.8%9.6%8.2%6.9%7.6%7.3%8.7%12.1%12.9%12.6%14.4%
Net debt/EBITDA -0.02x-0.23x0.06x0.52x1.12x0.90x0.59x0.84x0.73x2.02x1.03x1.86x2.22x2.12x2.52x2.21x
Current ratio 1.76x1.69x1.75x1.68x1.76x1.71x1.59x1.75x1.55x1.70x2.03x1.71x1.55x1.62x1.70x1.74x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarterrevenueprofitnet marginP/E TTMP/Bfiled on
2024T11,226.133.52.7%14.31.292024-05-15
2024T21,133.55.10.5%15.11.392024-08-14
2024T31,236.135.92.9%13.61.232024-11-13
2025T11,258.725.52.0%14.01.102025-05-14
2025T21,313.725.11.9%12.31.232025-08-14
2025T31,374.031.32.3%9.31.132025-11-06
2026T11,449.733.22.3%15.91.622026-05-06
2026T21,509.230.42.0%13.21.382026-08-06

Full series, every quarter: GET /empresas/PNVL3/trimestres

Dividends per year

yearper sharepayments
2026R$ 0.26847
2025R$ 0.19784
2024R$ 0.32208
2023R$ 0.19574
2022R$ 0.16603
2021R$ 0.12973
2020R$ 0.09063
2019R$ 2.76003

Piotroski F-Score 7/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal yearaccountfirst filingrestated
2017DRE 3.02-1,717.9-1,589.3
2017DRE 3.03528.2656.9
2021DRE 3.11.010.079.4
2012BPA 1.01.0114.39.1
2012BPA 1.01.020.05.2
2015BPA 1.01.019.114.2
2015BPA 1.01.025.10.0
2010DRE 3.03251.3247.8

This company appears in

Other companies in Consumer Cyclical

109 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/PNVL3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 3,424 sessions, 2010-01-05 → 2026-09-04 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 12:17 UTC. If this does not match /saude, you are reading a cached copy.